Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine*

Author： Nieoullon André   Bentué-Ferrer Danièle   Bordet Régis   Tsolaki Magda   Förstl Hans  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.12, 2008-12, pp. : 3357-3367

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease

By Vellas Bruno   Cunha Luís   Gertz Hermann-Josef   De Deyn Peter Paul   Wesnes Keith   Hammond Gerry   Schwalen Susanne    

Current Medical Research and Opinion, Vol. 21, Iss. 9, 2005-09 ,pp. : 1423-1430

Informa Healthcare

Access to resources Recommend Favorite

BACE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease: Focus on Bioactivity

By  

Recent Patents on CNS Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 91-106

Bentham Science Publishers

Access to resources Recommend Favorite

Magnesium and Alzheimer’s Disease: The Cholinergic Hypothesis

By  

Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine, Vol. 24, Iss. 6, 2012-11 ,pp. : 371-374

Karger

Access to resources Recommend Favorite

Clinical Studies of the Cholinergic Deficit in Alzheimer's Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 33, Iss. 11, 1985-11 ,pp. : 741-748

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neuropsychiatric Symptoms and Cholinergic Therapy for Alzheimer’s Disease

By  

Gerontology, Vol. 45, Iss. 1, 1999-01 ,pp. : 15-22

Karger

Access to resources Recommend Favorite